Paper37589901
Performance of [18F]FDG PET/CT versus FAPI PET/CT for lung cancer assessment: a systematic review and meta-analysis.
Yang Q and 9 others. Eur Radiol, 2024. Cited by 22 papers, by iCite.
Cite this record
ConductScience Library. Performance of [18F]FDG PET/CT versus FAPI PET/CT for lung cancer assessment: a systematic review and meta-analysis. Papers, record 37589901. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/37589901
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Performance of [18F]FDG PET/CT versus FAPI PET/CT for lung cancer assessment: a systematic review and meta-analysis.
- PubMed
Topics7
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Fluorodeoxyglucose F18 | Major topic |
| Positron Emission Tomography Computed Tomography | Major topic |
| Lung Neoplasms | Major topic |
| Radiopharmaceuticals | Major topic |
| Humans | |
| Sensitivity and Specificity | |
| Lymphatic Metastasis |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No. 2020LZXNYDJ12 | Luzhou Municipal People's Government-Southwest Medical University Science and Technology Strategic Cooperation Fund | PubMed |
Source PubMed
References40
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30323087 | NCCN Guidelines Insights: Small Cell Lung Cancer, Version 2.2018. | J Natl Compr Canc Netw | 2018 | https://conductscience.org/library/papers/30323087 | PubMed |
| 2 | 34870727 | [18F]AlF-NOTA-FAPI-04 PET/CT uptake in metastatic lesions on PET/CT imaging might distinguish different pathological types of lung cancer. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/34870727 | PubMed |
| 3 | 22007046 | QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. | Ann Intern Med | 2011 | https://conductscience.org/library/papers/22007046 | PubMed |
| 4 | 34814312 | Pathological analysis of hesperetin-derived small cell lung cancer by artificial intelligence technology under fiberoptic bronchoscopy. | Math Biosci Eng | 2021 | https://conductscience.org/library/papers/34814312 | PubMed |
| 5 | 14511930 | Whole-body positron emission tomography in patients with HIV-1 infection. | Lancet | 2003 | https://conductscience.org/library/papers/14511930 | PubMed |
| 6 | 33786982 | Phenotypic heterogeneity, stability and plasticity in tumor-promoting carcinoma-associated fibroblasts. | FEBS J | 2022 | https://conductscience.org/library/papers/33786982 | PubMed |
| 7 | 10561300 | Early detection and accurate description of extent of metastatic bone disease in breast cancer with fluoride ion and positron emission tomography. | J Clin Oncol | 1999 | https://conductscience.org/library/papers/10561300 | PubMed |
| 8 | 14665776 | Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings. | Respiration | 2003 | https://conductscience.org/library/papers/14665776 | PubMed |
| 9 | 32060216 | The Role of 68Ga-FAPI PET/CT for Patients with Malignancies of the Lower Gastrointestinal Tract: First Clinical Experience. | J Nucl Med | 2020 | https://conductscience.org/library/papers/32060216 | PubMed |
| 10 | 25880989 | The heterogeneity statistic I(2) can be biased in small meta-analyses. | BMC Med Res Methodol | 2015 | https://conductscience.org/library/papers/25880989 | PubMed |
| 11 | 35543731 | Higher accuracy of [68 Ga]Ga-DOTA-FAPI-04 PET/CT comparing with 2-[18F]FDG PET/CT in clinical staging of NSCLC. | Eur J Nucl Med Mol Imaging | 2022 | https://conductscience.org/library/papers/35543731 | PubMed |
| 12 | 12111919 | Quantifying heterogeneity in a meta-analysis. | Stat Med | 2002 | https://conductscience.org/library/papers/12111919 | PubMed |
| 13 | 34816283 | Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study. | Mol Imaging Biol | 2022 | https://conductscience.org/library/papers/34816283 | PubMed |
| 14 | 8622014 | Noninvasive monitoring of tumor metabolism using fluorodeoxyglucose and positron emission tomography in colorectal cancer liver metastases: correlation with tumor response to fluorouracil. | J Clin Oncol | 1996 | https://conductscience.org/library/papers/8622014 | PubMed |
| 15 | 17920724 | Lymph node staging by means of positron emission tomography is less accurate in non-small cell lung cancer patients with enlarged lymph nodes: analysis of 1,145 lymph nodes. | Lung Cancer | 2008 | https://conductscience.org/library/papers/17920724 | PubMed |
| 16 | 30776196 | Correlation between EGFR mutation status and F18 -fluorodeoxyglucose positron emission tomography-computed tomography image features in lung adenocarcinoma. | Thorac Cancer | 2019 | https://conductscience.org/library/papers/30776196 | PubMed |
| 17 | 33057927 | Improved cancer detection in Waldeyer's tonsillar ring by 68Ga-FAPI PET/CT imaging. | Eur J Nucl Med Mol Imaging | 2021 | https://conductscience.org/library/papers/33057927 | PubMed |
| 18 | 10485733 | 18F-fluorodeoxyglucose positron tomography in diagnosis of paediatric inflammatory bowel disease. | Lancet | 1999 | https://conductscience.org/library/papers/10485733 | PubMed |
| 19 | 34839457 | Cancer-associated fibroblasts in colorectal cancer. | Clin Transl Oncol | 2022 | https://conductscience.org/library/papers/34839457 | PubMed |
| 20 | 26471696 | TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT. | J Nucl Med | 2016 | https://conductscience.org/library/papers/26471696 | PubMed |
Cited by18
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 22 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42635770 | Clinical Evaluation of [18F]AlF-NOTA-GL01 PET/CT in patients with solid tumors: a prospective comparison with [18F]FDG and an exploratory [18F]FAPI-42 subset. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/42635770 | PubMed |
| 42529427 | Specific PET Imaging for Precision Management of Lung Cancer: Advances, Clinical Translation and Future Directions. | Chem Biomed Imaging | 2026 | https://conductscience.org/library/papers/42529427 | PubMed |
| 42243842 | Radionuclide‑drug conjugates in lung cancer: advances in precision therapy and clinical translation. | Mol Cancer | 2026 | https://conductscience.org/library/papers/42243842 | PubMed |
| 41945933 | Performance of [68Ga]Ga-FAPI PET in Breast, Ovarian, and Cervical Cancers: A Systematic Review and Meta-Analysis. | Asian Pac J Cancer Prev | 2026 | https://conductscience.org/library/papers/41945933 | PubMed |
| 41684586 | The comparative diagnostic and therapeutic application value of FAPI PET/CT and 18F-FDG PET/CT in oncology. | Front Oncol | 2026 | https://conductscience.org/library/papers/41684586 | PubMed |
| 41391071 | cGMP-compliant high-yield automated production of [18F]AlF-FAPI-74: optimization of quality control and evaluation of molar dose impact. | EJNMMI Radiopharm Chem | 2025 | https://conductscience.org/library/papers/41391071 | PubMed |
| 40805245 | Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40805245 | PubMed |
| 40773018 | Fibroblast activation Protein-Targeted PET/CT using [18 F]FAP-2286 for the evaluation of lung cancer: A comparative study with [18 F]FDG PET/CT. | Eur J Nucl Med Mol Imaging | 2026 | https://conductscience.org/library/papers/40773018 | PubMed |
| 40723177 | Characteristics of Oligo-Recurrence and Treatment Selection in Non-Small Cell Lung Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40723177 | PubMed |
| 40542914 | Protein-based Radiopharmaceuticals that target fibroblast activation protein alpha: a review of current progress. | EJNMMI Radiopharm Chem | 2025 | https://conductscience.org/library/papers/40542914 | PubMed |
| 40349083 | Revolutionizing cancer diagnosis and dose biodistribution: a meta-analysis of [68ga] FAPI- 46 vs. [18f] FDG imaging. | Syst Rev | 2025 | https://conductscience.org/library/papers/40349083 | PubMed |
| 40283957 | Fibroblast Activation Protein Inhibitor (FAPI)-Based Theranostics. | Pharmaceuticals (Basel) | 2025 | https://conductscience.org/library/papers/40283957 | PubMed |
| 40213678 | Therapeutic potential of FAPI RLT in oncology: A systematic review. | Theranostics | 2025 | https://conductscience.org/library/papers/40213678 | PubMed |
| 40126602 | Quantification of the immunohistochemical staining of fibroblast activation protein in intrathoracic solitary fibrous tumors using QuPath. | Surg Today | 2025 | https://conductscience.org/library/papers/40126602 | PubMed |
| 40083505 | Comparison of the diagnostic accuracy between 18F-FAPI-04 PET/CT and 18F-FDG PET/CT in the clinical stage IA of lung adenocarcinoma. | J Thorac Dis | 2025 | https://conductscience.org/library/papers/40083505 | PubMed |
| 39598380 | [68Ga]Ga-FAPI-46 PET/CT for Staging Suspected/Confirmed Lung Cancer: Results on the Surgical Cohort Within a Monocentric Prospective Trial. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39598380 | PubMed |
| 39011487 | Comparison of 68Ga-FAP-2286 and 18F-FDG PET/CT in the diagnosis of advanced lung cancer. | Front Oncol | 2024 | https://conductscience.org/library/papers/39011487 | PubMed |
| 37943314 | The impact of FAP imaging in lung cancer and beyond: a new chapter. | Eur Radiol | 2024 | https://conductscience.org/library/papers/37943314 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/37589901
GET https://conductscience.org/api/papers/v1/37589901/references?page=2